Galecto (GLTO) announced the appointment of Dr. Amy Wechsler to its Board of Directors. Since 2016, she has served on the Board of Directors for Bausch Health (BHC) where she played a key role in supporting the company through a successful IPO
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GLTO:
- Arcadium confirms Rio approach, Apollo funds to acquire Barnes: Morning Buzz
- Galecto completes strategic review, will focus on oncology, liver disease
- Galecto plans to file IND for BRM-1420 in late 2025/early 2026
- Galecto determines not to further advance GB2064
- Galecto Expands Oncology Portfolio with Strategic Acquisition